Your browser doesn't support javascript.
loading
Proteomic Correlates of the Urinary Protein/Creatinine Ratio in Heart Failure With Preserved Ejection Fraction.
Gan, Sushrima; Zhao, Lei; Salman, Oday; Wang, Zhaoqing; Ebert, Christina; Azzo, Joe David; Dib, Marie Joe; Zamani, Payman; Cohen, Jordana B; Kammerhoff, Karl; Schafer, Peter; Seiffert, Dietmar A; Ramirez-Valle, Francisco; Gordon, David A; Cvijic, Mary Ellen; Gunawardhana, Kushan; Liu, Laura; Chang, Ching-Pin; Cappola, Thomas P; Chirinos, Julio A.
Afiliação
  • Gan S; Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Division of Cardiovascular Medicine, Hospital of The University of Pennsylvania, Philadelphia, Pennsylvania.
  • Zhao L; Bristol-Myers Squibb Company, Lawrenceville, New Jersey.
  • Salman O; Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Division of Cardiovascular Medicine, Hospital of The University of Pennsylvania, Philadelphia, Pennsylvania.
  • Wang Z; Bristol-Myers Squibb Company, Lawrenceville, New Jersey.
  • Ebert C; Bristol-Myers Squibb Company, Lawrenceville, New Jersey.
  • Azzo JD; Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Division of Cardiovascular Medicine, Hospital of The University of Pennsylvania, Philadelphia, Pennsylvania.
  • Dib MJ; Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Division of Cardiovascular Medicine, Hospital of The University of Pennsylvania, Philadelphia, Pennsylvania.
  • Zamani P; Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Division of Cardiovascular Medicine, Hospital of The University of Pennsylvania, Philadelphia, Pennsylvania.
  • Cohen JB; Renal-Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Biostatistics, Epidemiology, and Informatics.
  • Kammerhoff K; Bristol-Myers Squibb Company, Lawrenceville, New Jersey.
  • Schafer P; Bristol-Myers Squibb Company, Lawrenceville, New Jersey.
  • Seiffert DA; Bristol-Myers Squibb Company, Lawrenceville, New Jersey.
  • Ramirez-Valle F; Bristol-Myers Squibb Company, Lawrenceville, New Jersey.
  • Gordon DA; Bristol-Myers Squibb Company, Lawrenceville, New Jersey.
  • Cvijic ME; Bristol-Myers Squibb Company, Lawrenceville, New Jersey.
  • Gunawardhana K; Bristol-Myers Squibb Company, Lawrenceville, New Jersey.
  • Liu L; Bristol-Myers Squibb Company, Lawrenceville, New Jersey.
  • Chang CP; Bristol-Myers Squibb Company, Lawrenceville, New Jersey.
  • Cappola TP; Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Division of Cardiovascular Medicine, Hospital of The University of Pennsylvania, Philadelphia, Pennsylvania.
  • Chirinos JA; Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Division of Cardiovascular Medicine, Hospital of The University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: julio.chirinos@uphs.upenn.edu.
Am J Cardiol ; 206: 312-319, 2023 11 01.
Article em En | MEDLINE | ID: mdl-37734292
ABSTRACT
Proteinuria is common in heart failure with preserved ejection fraction (HFpEF), but its biologic correlates are poorly understood. We assessed the relation between 49 plasma proteins and the urinary protein/creatinine ratio (UPCR) in 365 participants in the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial. Linear regression and network analysis were used to represent relations between protein biomarkers and UPCR. Higher UPCR was associated with older age, a greater proportion of female gender, smaller prevalence of previous myocardial infarction, and greater prevalence of diabetes, insulin use, smoking, and statin use, in addition to a lower estimated glomerular filtration rate, hematocrit, and diastolic blood pressure. Growth differentiation factor 15 (GDF-15; ß = 0.15, p <0.0001), followed by N-terminal proatrial natriuretic peptide (NT-proANP; ß = 0.774, p <0.0001), adiponectin (ß = 0.0005, p <0.0001), fibroblast growth factor 23 (FGF-23, ß = 0.177; p <0.0001), and soluble tumor necrosis factor receptors I (ß = 0.002, p <0.0001) and II (ß = 0.093, p <0.0001) revealed the strongest associations with UPCR. Network analysis showed that UPCR is linked to various proteins primarily through FGF-23, which, along with GDF-15, indicated node characteristics with strong connectivity, whereas UPCR did not. In a model that included FGF-23 and UPCR, the former was predictive of the risk of death or heart-failure hospital admission (standardized hazard ratio 1.83, 95% confidence interval 1.49 to 2.26, p <0.0001) and/or all-cause death (standardized hazard ratio 1.59, 95% confidence interval 1.22 to 2.07, p = 0.0005), whereas UPCR was not prognostic. Proteinuria in HFpEF exhibits distinct proteomic correlates, primarily through its association with FGF-23, a well-known prognostic marker in HFpEF. However, in contrast to FGF-23, UPCR does not hold independent prognostic value.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Insuficiência Cardíaca Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Insuficiência Cardíaca Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article